From the June 2018 issue of HealthCare Business News magazine
Clinicians could also increasingly rely on AI as a powerful tool to help identify cancer and its subtypes, inflammatory response or scan irregularities. While these tools will by no means replace clinicians, they will free up time, allowing doctors to focus on delivering the best patient care.
But this cannot be realized without smart data integration and partnership between hospitals and vendors. All inputs, like in vivo and in vitro data, will need to be integrated and analyzed so clinicians can see a patient’s profile in a snapshot – this is something my company is already working on with Roche. The first step in accomplishing this is improving data integration and ensuring the IT infrastructure can quickly and intelligently leverage information.
Ad Statistics
Times Displayed: 365831
Times Visited: 7093 Quality remanufactured Certified Centrifuges at Great prices! Fully warranted and backed by a company you can trust! Call or click for a free quote today! www.Centrifugestore.com 800-457-7576
While this may sound like science fiction today, many organizations are already taking steps to turn this vision into a reality, integrating digital diagnostics to improve patients’ treatment strategies. Molecular imaging will continue to play a critical role in reshaping healthcare for doctors and patients, now and in the future.
About the author: Mike Barber is the president & CEO of Molecular Imaging & CT at GE Healthcare.
Back to HCB News
